Reuters logo
BRIEF-Cytosorbents posts safety data from Refresh I cardiac surgery trial
October 5, 2016 / 11:16 AM / a year ago

BRIEF-Cytosorbents posts safety data from Refresh I cardiac surgery trial

Oct 5 (Reuters) - Cytosorbents Corp:

* Announces positive top line safety data from refresh I cardiac surgery trial

* DSMB found no safety concerns related to Cytosorb device, achieving primary safety endpoint Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below